Alendronate osteoporosis drug molecule

Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Alendronate osteoporosis drug, molecular model. Alendronate is marketed as Fosamax, or as Fosavance when combined with vitamin D. It is a bisphosphonate drug, which works by blocking the resorption of bone by osteoclast bone cells. The treatment requires healthy levels of calcium and vitamin D, so if the underlying problem is with levels of either of those, that must be corrected before the course starts. In this molecule, atoms are shown as balls and are colour-coded: carbon (green), nitrogen (blue), hydrogen (white), phosphorus (orange) and oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: ageing, alendronate, artwork, ball and stick, biochemical, biochemistry, bisphosphonate, bone, bones, brittle bone disease, chemical, chemistry, compound, compounds, computer artwork, density, drug, elderly, fosamax, fosavance, illustration, mass, medical, medicine, molecular, molecular model, molecule, molecules, one, osteoporosis, pharmaceutical, pharmaceutics, pharmacological, pharmacology, resorption, single

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.